These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 21188771
1. Adding telaprevir improves cure rate in patient with HCV infection. AIDS Patient Care STDS; 2010 Dec; 24(12):807. PubMed ID: 21188771 [No Abstract] [Full Text] [Related]
2. Telaprevir (Incivek) and boceprevir (Victrelis) for chronic hepatitis C. Med Lett Drugs Ther; 2011 Jul 25; 53(1369):57-9. PubMed ID: 21778964 [No Abstract] [Full Text] [Related]
3. Treatment duration for genotypes 2 and 3: still confusing after all these years. Jensen DM. J Clin Gastroenterol; 2010 Sep 25; 44(8):527-8. PubMed ID: 20628314 [No Abstract] [Full Text] [Related]
4. ADVANCE study begins enrollment. AIDS Patient Care STDS; 2008 Apr 25; 22(4):345. PubMed ID: 18422463 [No Abstract] [Full Text] [Related]
5. Telaprevir phase 3 realize trial starts. AIDS Patient Care STDS; 2008 Oct 25; 22(10):837. PubMed ID: 18847391 [No Abstract] [Full Text] [Related]
6. Telaprevir for the treatment of chronic hepatitis C infection. Muir AJ. Expert Rev Anti Infect Ther; 2011 Dec 25; 9(12):1105-14. PubMed ID: 22114960 [Abstract] [Full Text] [Related]
7. Delaying HCV treatment in HIV-positive patients. Carter M. IAPAC Mon; 2005 May 25; 11(5):147. PubMed ID: 16201045 [No Abstract] [Full Text] [Related]
9. Telaprevir. Drugs R D; 2010 Dec 15; 10(3):179-202. PubMed ID: 20945948 [Abstract] [Full Text] [Related]
10. Hepatitis C cure after 6 months of telaprevir-based therapy in an HIV-infected man. Cachay ER. Clin Infect Dis; 2013 Jan 15; 56(1):163-4. PubMed ID: 23001703 [No Abstract] [Full Text] [Related]
11. [Possible telaprevir-induced pancreatitis. A case study]. Selvi Sabater P, Espuny Miró A, Muñoz Bertrán ED, Plaza Aniorte J. Farm Hosp; 2013 Jan 15; 37(3):269-70. PubMed ID: 23789806 [No Abstract] [Full Text] [Related]
12. Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C. Aghemo A, Rumi MG, Colombo M. Expert Rev Anti Infect Ther; 2009 Oct 15; 7(8):925-35. PubMed ID: 19803700 [Abstract] [Full Text] [Related]
13. [Telaprevir-induced pityriasis rubra pilaris]. Schmutz JL, Trechot P. Ann Dermatol Venereol; 2013 May 15; 140(5):414-5. PubMed ID: 23663723 [No Abstract] [Full Text] [Related]
15. "Hepatitis C (HCV) treatment is not a "one size fits all". Bukeirat FA, Bukeirat MM. W V Med J; 2012 Jul 15; 108(2):20, 22-4. PubMed ID: 22655431 [Abstract] [Full Text] [Related]
16. Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients. Chen J, Shi J, Xie WF, Zeng X, Lin Y. Int J Infect Dis; 2012 Oct 15; 16(10):e748-52. PubMed ID: 22836046 [Abstract] [Full Text] [Related]
17. [Treatment of hepatitis C virus infection]. Zeuzem S. Praxis (Bern 1994); 2005 May 04; 94(18):721-6. PubMed ID: 15938383 [Abstract] [Full Text] [Related]
18. Second thoughts about secondary analyses. Ferenci P. Dig Liver Dis; 2005 Oct 04; 37(10):805-7; author reply 808-9. PubMed ID: 16023903 [No Abstract] [Full Text] [Related]
19. Ribavirin in chronic hepatitis C: past and future. Loustaud-Ratti V, Rousseau A, Marquet P, Denis F, Alain S. Expert Rev Anti Infect Ther; 2009 Apr 04; 7(3):249-53. PubMed ID: 19344238 [No Abstract] [Full Text] [Related]
20. [Genotype 1 superresponder treat for only 24 weeks]. MMW Fortschr Med; 2005 Dec 15; 147(51-52):69. PubMed ID: 16402717 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]